BioXcel Therapeutics, Inc. (BTAI)
0.0739
-0.04
(-37.11%)
USD |
NASDAQ |
Sep 04, 16:00
0.0434
-0.03
(-41.27%)
After-Hours: 20:00
BioXcel Therapeutics Debt to Equity Ratio : -0.9047 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.9047 |
| March 31, 2026 | -0.9502 |
| December 31, 2025 | -1.251 |
| September 30, 2025 | -1.229 |
| June 30, 2025 | -1.012 |
| March 31, 2025 | -1.174 |
| December 31, 2024 | -1.106 |
| September 30, 2024 | -1.226 |
| June 30, 2024 | -1.395 |
| March 31, 2024 | -1.414 |
| December 31, 2023 | -1.794 |
| September 30, 2023 | -2.462 |
| June 30, 2023 | 16.68 |
| March 31, 2023 | 1.816 |
| December 31, 2022 | 1.228 |
| September 30, 2022 | 0.732 |
| June 30, 2022 | 0.3795 |
| March 31, 2022 | 0.0068 |
| December 31, 2021 | 0.0063 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.006 |
| June 30, 2021 | 0.0057 |
| March 31, 2021 | 0.0086 |
| December 31, 2020 | 0.0079 |
| September 30, 2020 | 0.0076 |
| June 30, 2020 | 0.0206 |
| March 31, 2020 | 0.0159 |
| December 31, 2019 | 0.0444 |
| September 30, 2019 | 0.0358 |
| June 30, 2019 | 0.0505 |
| March 31, 2019 | 0.0404 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.3778 |
| September 30, 2017 | |
| December 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Anika Therapeutics, Inc. | 0.1839 |
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 28.80M |
| Total Liabilities (Quarterly) | 144.26M |
| Shareholders Equity (Quarterly) | -115.46M |
| Current Ratio | 0.2093 |
| Net Debt Paydown Yield | 0.66% |